Novoviah

Novoviah is a biotechnology company focused on enabling precise, ultrasensitive monitoring of antigen-specific T cell responses. Novoviah’s Novoleukin Test System is a whole-blood, antigen-stimulated cytokine release assay designed to detect rare antigen-specific T cells with sensitivity beyond conventional methods, while simplifying sample handling for multi-site clinical studies.

Novoviah partners with biopharma and academic teams to deliver tailored immune monitoring solutions across autoimmune disease, vaccine, and immunotherapy programs, with flagship products in Celiac Disease and Type 1 Diabetes. By providing high-resolution insight into antigen-specific immune dynamics, Novoviah’s technology supports the development and evaluation of targeted immune-modulating therapies, including approaches focused on immune tolerance.